ClassID:

96480

C07J5/00 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Sub-classes:
Recent Application in this class:
#1
20260102373
2026-04-16

LYMPH DIRECTING PRODRUGS

#2
20250352510
2025-11-20

LYMPH DIRECTING PRODRUGS

#3
20250213522
2025-07-03

LYMPH DIRECTING PRODRUGS

#4
20220211664
2022-07-07

LYMPH DIRECTING PRODRUGS

#5
20220002338
2022-01-06

CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL

#6
20200190133
2020-06-18

Crystalline solvate forms of a pharmaceutical

#7
20170326103
2017-11-16

Lymph directing prodrugs

#8
20170281648
2017-10-05

DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE

#9
20160175322
2016-06-23

Treatment methods using pharmaceutical solid state forms

#10
20160083415
2016-03-24

Crystalline anhydrate forms of a pharmaceutical

#11
20160045516
2016-02-18

Treatment methods using pharmaceutical solid state forms

#12
20140370097
2014-12-18

Sterile pharmaceutical compositions

#13
20140107328
2014-04-17

Chemoselective enrichment for compound isolation

#14
20130225594
2013-08-29

Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions

#15
20120302537
2012-11-29

TREATMENT METHODS USING PHARMACEUTICAL SOLID STATE FORMS

#16
20120296105
2012-11-22

CRYSTALLINE ANHYDRATE FORMS OF A PHARMACEUTICAL

#17
20120070499
2012-03-22

DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE

#18
20100324004
2010-12-23

Method for treating diabetes

#19
20100113408
2010-05-06

21-substituted progesterone derivatives as new antiprogestational agents

#20
20090291933
2009-11-26

Solid state forms of a pharmaceutical

#21
20090281071
2009-11-12

Therapeutic agent for hypertension

#22
20090081297
2009-03-26

Use of surface tension reducing agents in aerosol formulations

#23
20080234506
2008-09-25

Process for the preparation of fluorotetraene

#24
20080221072
2008-09-11

Fatty Acid Modified Forms of Glucocorticoids

#25
20080139519
2008-06-12

Heat sterilization of glucocorticosteroids

#26
20080076743
2008-03-27

Delayed-Release Glucocorticoid treatment of Rheumatoid Disease

#27
20070298456
2007-12-27

Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof

#28
20070212751
2007-09-13

Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods

#29
20070203106
2007-08-30

Method for Producing 5Alpha-Pregnane Derivative

#30
20070203105
2007-08-30

Progesterone receptor modulators

#31
20070197490
2007-08-23

Method for producing 5alpha-pregnane derivative

#32
20070155781
2007-07-05

Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders

#33
20070149494
2007-06-28

Method for producing 5alpha-pregnane derivative

#34
20070129332
2007-06-07

Processes to prepare eplerenone

#35
20070082876
2007-04-12

Novel C18 modified retrosteroids as progesterone receptor modulator compounds

#36
20070060555
2007-03-15

Fatty acid modified forms of glucocorticoids

#37
20060276443
2006-12-07

21-substituted progesterone derivatives as new antiprogestational agents

#38
20060247452
2006-11-02

Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione

#39
20060183727
2006-08-17

Estrogenic compounds as anti-mitotic agents

#40
20060173201
2006-08-03

Process for the production of tibolone

#41
20060148773
2006-07-06

Novel steroidal antiestrogens and antiandrogens and uses thereof

#42
20060111577
2006-05-25

Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates

#43
20050222109
2005-10-06

Crystalline 19-norsteroids

#44
20050143365
2005-06-30

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

#45
20050143364
2005-06-30

21-substituted progesterone derivatives as new antiprogestational agents

#46
20050090675
2005-04-28

Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof

#47
20050090477
2005-04-28

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

#48
20050085452
2005-04-21

Process for the synthesis of pharmacologically active (z/e)-guggulsterones

#49
20050065135
2005-03-24

8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes

#50
20050009801
2005-01-13

Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one